Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHAT Phathom Pharmaceuticals

盘前交易 03-05 06:12:50 EST

11.06

+0.01

+0.09%

盘前11.30

+0.24+2.17%

05:11 EST

最高11.85	最低11.00	成交量57.03万
今开11.22	昨收11.05	日振幅7.72%
总市值8.72亿	流通市值6.37亿	总股本7,880万
成交额637.89万	换手率0.99%	流通股本5,757万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":11.06,"timestamp":1772658000000,"preClose":11.05,"halted":0,"volume":570309,"hourTrading":{"tag":"盘前","latestPrice":11.3,"preClose":11.06,"latestTime":"05:11 EST","volume":8019,"amount":90593.706258,"timestamp":1772705489327,"change":0.24,"changeRate":0.0217,"amplitude":0.035262},"delay":0,"changeRate":0.0009049773755655915,"floatShares":57566899,"shares":78798712,"eps":-3.034157,"marketStatus":"盘前交易","change":0.01,"latestTime":"03-05 06:12:50 EST","open":11.22,"high":11.8535,"low":11,"amount":6378943.805394,"amplitude":0.07724,"askPrice":11.7,"askSize":100,"bidPrice":10.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.034157,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772721000000},"marketStatusCode":1,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":11.06,"preHourTrading":{"tag":"盘前","latestPrice":11.3,"preClose":11.06,"latestTime":"05:11 EST","volume":8019,"amount":90593.706258,"timestamp":1772705489327,"change":0.24,"changeRate":0.0217,"amplitude":0.035262},"postHourTrading":{"tag":"盘后","latestPrice":11.06,"preClose":11.06,"latestTime":"16:27 EST","volume":9281,"amount":102690.86,"timestamp":1772659649038,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3703819402764941,"impliedVol":0.8944,"impliedVolPercentile":0.304},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2603572114","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603572114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603572114?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229118,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报14.26美元/股，成交量25.3004万股，换手率0.32%，振幅5.00%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Day One Biopharmaceuticals, Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为539.06%、111.98%、48.43%，振幅较大的相关个股有Pyxis Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs, Inc.，振幅分别为26.42%、25.56%、24.64%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"1100611774","title":"Phathom Pharmaceuticals公布1.3亿美元普通股及预先注资认股权证公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1100611774","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100611774?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:34","pubTimestamp":1767843258,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals今日正式宣布，已完成其普通股及预先注资认股权证公开发行的定价工作。此次发行规模总计高达1.3亿美元，标志着公司在资本市场的又一重要融资举措。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"1108691297","title":"Phathom Pharmaceuticals宣布首名患者在Eosinophilic Esophagitis (Eoe)的Voquezna® (Vonoprazan)二期研究中接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1108691297","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108691297?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:01","pubTimestamp":1762261298,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals宣布首名患者在Eosinophilic Esophagitis (Eoe)的Voquezna® (Vonoprazan)二期研究中接受治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"1129363798","title":"Phathom Pharmaceuticals将于2025年10月30日公布2025年第三季度财务业绩及业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1129363798","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129363798?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961694,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals将于2025年10月30日公布2025年第三季度财务业绩及业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2575235067","title":"Phathom Pharmaceuticals, Inc.盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575235067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575235067?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:32","pubTimestamp":1760383967,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日03时32分，Phathom Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.08%。截至发稿，该股报12.42美元/股，成交量65.7152万股，换手率0.93%，振幅6.18%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Compugen医疗、Nanobiotix、天境生物涨幅较大，Quoin Pharmaceuticals Ltd、Tvardi Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为127.11%、63.02%、41.56%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为41.90%、36.36%、34.94%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014033247a45e2bcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014033247a45e2bcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2572719703","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速上涨5.12%报11.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572719703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572719703?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:05","pubTimestamp":1759241129,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时05分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报11.91美元/股，成交量8.575万股，换手率0.12%，振幅5.30%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Anaptysbio, Inc.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1742.43%、285.41%、256.74%，振幅较大的相关个股有Scisparc Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Anaptysbio, Inc.，振幅分别为28.48%、26.06%、24.54%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220529971a74b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220529971a74b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518205329","title":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205329?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628482,"startTime":"0","endTime":"0","summary":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11014148641581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2518227203","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227203?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613580,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Phathom Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.24%。截至发稿，该股报4.80美元/股，成交量7.1426万股，换手率0.10%，振幅4.20%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2045.40%、403.94%、59.60%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518289792","title":"Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元，同比减少65.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289792?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536072,"startTime":"0","endTime":"0","summary":"3月10日，Phathom Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-3.34亿美元，同比减少65.35%；其中营业收入为55.25百万美元，同比增加8001.17%，每股基本收益为-5.29美元。机构评级：截至2025年3月10日，当前有8家机构对Phathom Pharmaceuticals, Inc.目标价做出预测，其中目标均价为21.62美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT"],"gpt_icon":0},{"id":"2517152379","title":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152379","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517152379?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:12","pubTimestamp":1741266750,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06211248574105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"1118505333","title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1118505333","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118505333?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:10","pubTimestamp":1741266636,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals报告本季度每股亏损$，超过分析师共识预期的$，提高了37.8%。这比去年同期每股亏损$增加了1.25%。这比去年同期销售额$682,000增长了4,250%。以上内容来自Benzinga Earnings专栏，原文如下：$Phathom Pharmaceuticals$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 37.8 percent. This is a 1.25 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent.  This is a","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"gpt_icon":0},{"id":"2517284609","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517284609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517284609?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:28","pubTimestamp":1741199304,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时28分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为950.81%、305.93%、302.22%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2517985659","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985659?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:15","pubTimestamp":1741119353,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时15分，Phathom Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.37%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hoth Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1326.08%、1255.21%、1219.34%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2514937556","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937556?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:56","pubTimestamp":1740754592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.21%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Enveric Biosciences, Inc.、Puma Biotechnology Inc、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为626.68%、367.39%、303.39%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、35.13%、29.25%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2514866851","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866851?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.38%。截至发稿，该股报5.88美元/股，成交量5.9977万股，换手率0.09%，振幅2.06%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2798.65%、116.09%、90.30%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为29.66%、16.86%、14.35%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2514155390","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514155390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514155390?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:07","pubTimestamp":1740496063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时07分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.24%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1028.28%、777.69%、580.87%，振幅较大的相关个股有Organovo Holdings, Inc.、Gri Bio, Inc.、Adial Pharmaceuticals, Inc，振幅分别为121.95%、56.51%、47.10%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2514703852","title":"Phathom Pharmaceuticals, Inc.盘中异动 急速下跌5.03%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703852?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:16","pubTimestamp":1740428178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时16分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.03%。截至发稿，该股报5.39美元/股，成交量79.7323万股，换手率1.17%，振幅5.47%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为326.72%、141.67%、40.73%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2511520426","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511520426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511520426?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:49","pubTimestamp":1739465351,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时49分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报5.76美元/股，成交量12.9359万股，换手率0.19%，振幅6.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2828.37%、1194.06%、167.30%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2510920867","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅下挫5.08%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510920867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510920867?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:35","pubTimestamp":1739205336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时35分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.08%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2828.04%、1570.44%、1105.50%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003536961e181e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003536961e181e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2509747305","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.08%报5.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509747305?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:59","pubTimestamp":1738940348,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时59分，Phathom Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.08%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为3150.25%、81.27%、67.95%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、45.02%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225909987db261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225909987db261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.1023},{"period":"1month","weight":-0.1991},{"period":"3month","weight":-0.2476},{"period":"6month","weight":-0.1037},{"period":"1year","weight":0.9821},{"period":"ytd","weight":-0.3333}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司，专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119818},{"month":4,"riseRate":0.5,"avgChangeRate":0.053339},{"month":5,"riseRate":0.5,"avgChangeRate":-0.02431},{"month":6,"riseRate":0.666667,"avgChangeRate":0.246775},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025067},{"month":8,"riseRate":0.666667,"avgChangeRate":0.15186},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003613},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}